Your session is about to expire
← Back to Search
Tobacco Treatment Specialist (TTS) intervention for Cystic Fibrosis (CEASE-CF Trial)
N/A
Waitlist Available
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Adult familial caregiver of a child with CF aged <18 years
Speak English
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
CEASE-CF Trial Summary
This trial will test a new smoking cessation program designed specifically for caregivers of children with CF. The goal is to help these caregivers quit smoking, and reduce the exposure of children with CF to tobacco smoke.
Eligible Conditions
- Cystic Fibrosis
CEASE-CF Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowCEASE-CF Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Intervention acceptability
Intervention feasibility
Secondary outcome measures
Child smoke exposure
Self-reported caregiver cessation
CEASE-CF Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention groupExperimental Treatment1 Intervention
The intervention group will receive the multi-component intervention (counseling with intake assessment, follow-up, help obtaining nicotine replacement therapy, and CF-specific smoke exposure education)
Group II: Control groupActive Control1 Intervention
The control group will receive usual care plus CF-specific smoke exposure education.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Tobacco Treatment Specialist (TTS) intervention
2021
N/A
~40
Find a Location
Who is running the clinical trial?
Cystic Fibrosis FoundationOTHER
187 Previous Clinical Trials
36,327 Total Patients Enrolled
180 Trials studying Cystic Fibrosis
33,390 Patients Enrolled for Cystic Fibrosis
University of Alabama at BirminghamLead Sponsor
1,566 Previous Clinical Trials
2,268,611 Total Patients Enrolled
22 Trials studying Cystic Fibrosis
41,053 Patients Enrolled for Cystic Fibrosis
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger